Skip to content

A Clinical Study on the Efficacy and Safety of Low-Intensity Monochromatic Red-Light Therapy for Myopia Control in Children With Different Degrees of Myopia

A Clinical Study on the Efficacy and Safety of Low-Intensity Monochromatic Red-Light Therapy for Myopia Control in Children With Different Degrees of Myopia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124075
Enrollment
Unknown
Registered
2026-05-07
Start date
2025-07-27
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Low Myopia group:Participants were instructed to wear the spectacles for a minimum of 12 hours per day while concurrently undergoing repeated low-level red-light therapy twice daily, with each session
Moderate Myopia group:Participants were instructed to wear the spectacles for a minimum of 12 hours per day while concurrently undergoing repeated low-level red-light therapy twice daily, with each se
High Myopia group:Participants were instructed to wear the spectacles for a minimum of 12 hours per day while concurrently undergoing repeated low-level red-light therapy twice daily, with each sessio

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Children and adolescents aged 6–16 years at the time of data collection, meeting the standard eligibility requirements for the RLRL device. 2. A clinical diagnosis of myopia. 3. Best-corrected visual acuity (BCVA) of 16/20 or better.

Exclusion criteria

Exclusion criteria: 1. Participants diagnosed with strabismus or amblyopia. 2. Secondary myopia resulting from congenital ocular disorders or ocular manifestations of systemic syndromes (e.g., congenital cataract, congenital retinal disease, retinopathy of prematurity), or myopia associated with systemic syndromes such as Marfan syndrome. 3. Opacification of the refractive media, including corneal abnormalities and lens opacity. 4. Presence of fundus lesions, optic neuropathy, or other intraocular diseases. 5. Previous corneal surgery or intraocular surgery. 6. Any other reason deemed by the investigator to render the participant unsuitable for enrollment

Design outcomes

Primary

MeasureTime frame
axial length, AL;

Secondary

MeasureTime frame
spherical equivalent refraction, SER;Choroidal thickness below the macular fovea;

Countries

China

Contacts

Public ContactTan Qingqing

Department of Ophthalmology, Affiliated Hospital of North Sichuan Medical College

tqq0720@126.com+86 138 9083 4742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026